Jazz Pharmaceuticals
JAZZ
JAZZ
405 hedge funds and large institutions have $6.55B invested in Jazz Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 161 increasing their positions, 137 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
405
Holders Change
-10
Holders Change %
-2.41%
% of All Funds
8.9%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
44
Increased
161
Reduced
137
Closed
54
Calls
$35.5M
Puts
$30.1M
Net Calls
+$5.43M
Net Calls Change
-$2.86M
Top Buyers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$76.1M |
| 2 |
Renaissance Technologies
New York
|
+$72M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$35.1M |
| 4 |
Goldman Sachs
New York
|
+$35M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.8M |
